Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK

Simon Ball, Amitava Banerjee, Colin Berry, Jonathan R Boyle, Benjamin Bray, William Bradlow, Afzal Chaudhry, Rikki Crawley, John Danesh, Alastair Denniston, Florian Falter, Jonine D Figueroa, Christopher Hall, Harry Hemingway, Emily Jefferson, Tom Johnson, Graham King, Kuan Ken Lee, Paul McKean, Suzanne Mason, Nicholas L Mills, Ewen Pearson, Munir Pirmohamed, Michael T C Poon, Rouven Priedon, Anoop Shah, Reecha Sofat, Jonathan A C Sterne, Fiona E Strachan, Cathie L M Sudlow, Zsolt Szarka, William Whiteley, Michael Wyatt, CVD-COVID-UK Consortium, Simon Ball, Amitava Banerjee, Colin Berry, Jonathan R Boyle, Benjamin Bray, William Bradlow, Afzal Chaudhry, Rikki Crawley, John Danesh, Alastair Denniston, Florian Falter, Jonine D Figueroa, Christopher Hall, Harry Hemingway, Emily Jefferson, Tom Johnson, Graham King, Kuan Ken Lee, Paul McKean, Suzanne Mason, Nicholas L Mills, Ewen Pearson, Munir Pirmohamed, Michael T C Poon, Rouven Priedon, Anoop Shah, Reecha Sofat, Jonathan A C Sterne, Fiona E Strachan, Cathie L M Sudlow, Zsolt Szarka, William Whiteley, Michael Wyatt, CVD-COVID-UK Consortium

Abstract

Objective: To monitor hospital activity for presentation, diagnosis and treatment of cardiovascular diseases during the COVID-19) pandemic to inform on indirect effects.

Methods: Retrospective serial cross-sectional study in nine UK hospitals using hospital activity data from 28 October 2019 (pre-COVID-19) to 10 May 2020 (pre-easing of lockdown) and for the same weeks during 2018-2019. We analysed aggregate data for selected cardiovascular diseases before and during the epidemic. We produced an online visualisation tool to enable near real-time monitoring of trends.

Results: Across nine hospitals, total admissions and emergency department (ED) attendances decreased after lockdown (23 March 2020) by 57.9% (57.1%-58.6%) and 52.9% (52.2%-53.5%), respectively, compared with the previous year. Activity for cardiac, cerebrovascular and other vascular conditions started to decline 1-2 weeks before lockdown and fell by 31%-88% after lockdown, with the greatest reductions observed for coronary artery bypass grafts, carotid endarterectomy, aortic aneurysm repair and peripheral arterial disease procedures. Compared with before the first UK COVID-19 (31 January 2020), activity declined across diseases and specialties between the first case and lockdown (total ED attendances relative reduction (RR) 0.94, 0.93-0.95; total hospital admissions RR 0.96, 0.95-0.97) and after lockdown (attendances RR 0.63, 0.62-0.64; admissions RR 0.59, 0.57-0.60). There was limited recovery towards usual levels of some activities from mid-April 2020.

Conclusions: Substantial reductions in total and cardiovascular activities are likely to contribute to a major burden of indirect effects of the pandemic, suggesting they should be monitored and mitigated urgently.

Keywords: aortic and arterial disease; epidemiology; global health care delivery; health care delivery; heart disease.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Overall hospital activity (admissions, ED attendances and COVID-19 admissions) between 31 October 2019 and 10 May 2020 compared with the same weeks from 2018 to 2019. Lines describe the mean hospital activities in 2019–2020 (solid) and 2018–2019 (dotted). Shading represents 95% CI of the respective hospital activity. The first case of COVID-19 was on 31 January 2020 and lockdown started on 23 March 2020. ED, emergency department.
Figure 2
Figure 2
Percentage change compared with the previous year in ED attendances and hospital admissions for individual hospitals. Eight hospitals provided data on hospital admissions and five hospitals (A, B, C, D and H) also provided data on ED attendances. Hospital G did not provide these hospital statistics and is not shown. ED, emergency department.
Figure 3
Figure 3
% change compared with the previous year in ED attendance, hospital admissions and procedures/treatments for cardiac, cerebrovascular and other vascular conditions. Cardiac ED attendances are those with an ED diagnosis code for cardiac conditions; cardiac admissions include those with acute coronary syndrome or heart failure; cardiac procedures/treatments include percutaneous coronary intervention, cardiac pacemaker or resynchronisation and coronary artery bypass graft; cerebrovascular ED attendances are those with an ED diagnosis code for cerebrovascular conditions; cerebrovascular admissions include those with acute stroke (ischaemic, intracerebral haemorrhage or subarachnoid haemorrhage) or transient ischaemic attack; cerebrovascular procedures/treatments include stroke thrombolysis, thrombectomy, carotid endarterectomy/stenting or cerebral aneurysm coiling; other vascular ED attendances are those with an ED diagnosis code for other vascular conditions; other vascular admissions include those with aortic aneurysms, DVT, PE or peripheral arterial disease; other vascular procedures include aortic aneurysm repair, limb revascularisation, bypass or amputation and peripheral angioplasty. Horizontal brown line indicates 0%; vertical green dotted line indicates first confirmed COVID-19 case on 31 January 2020; vertical purple dotted line indicates lockdown date on 23 March 2020. Shading represents 95% CIs of % change. DVT, deep vein thrombosis; ED, emergency department; PE, pulmonary embolism.
Figure 4
Figure 4
Relative reductions in hospital activities during the COVID-19 pandemic. Relative reduction (RR) comparing phase 2 (between first case and lockdown) and phase 3 (after lockdown) to phase 1 (before first case). ACS, acute coronary syndrome; CABG, coronary artery bypass graft; DVT, deep vein thrombosis; ED, emergency department; PCI, percutaneous coronary interventions; PE, pulmonary embolus; TIA, transient ischaemic attack.

References

    1. Banerjee A, Pasea L, Harris S, et al. . Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Lancet 2020;395:1715–25. 10.1016/S0140-6736(20)30854-0
    1. Kluge HHP, Wickramasinghe K, Rippin HL, et al. . Prevention and control of non-communicable diseases in the COVID-19 response. Lancet 2020;395:1678–80. 10.1016/S0140-6736(20)31067-9
    1. James SL, Abate D, Abate KH, et al. . Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet 2018;392:1789–858. 10.1016/S0140-6736(18)32279-7
    1. Newton JN, Briggs ADM, Murray CJL, et al. . Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the global burden of disease study 2013. The Lancet 2015;386:2257–74. 10.1016/S0140-6736(15)00195-6
    1. Docherty AB, Harrison EM, Green CA, et al. . Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985. 10.1136/bmj.m1985
    1. Richardson S, Hirsch JS, Narasimhan M, et al. . Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA 2020;323:2052. 10.1001/jama.2020.6775
    1. Public Health England Guidance on social distancing for everyone in the UK and protecting older people and vulnerable adults, 2020. Available: [Accessed 16 Mar 2016].
    1. Bhatt AS, Moscone A, McElrath EE, et al. . Declines in hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic: a multicenter tertiary care experience. J Am Coll Cardiol 2020;76:280–8.
    1. De Filippo O, D'Ascenzo F, Angelini F, et al. . Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy. N Engl J Med 2020;383:88–9. 10.1056/NEJMc2009166
    1. Banerjee A, Chen S, Pasea L, et al. . Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Cardiovascular Medicine 2020.
    1. Bromage DI, Cannatà A, Rind IA, et al. . The impact of COVID-19 on heart failure hospitalization and management: report from a heart failure unit in London during the peak of the pandemic. Eur J Heart Fail 2020;22:978–84. 10.1002/ejhf.1925
    1. Figueroa J, Brennan P, Theodoratou E, et al. . Trends in excess cancer and cardiovascular deaths in Scotland during the COVID-19 pandemic 30 December 2019 to 20 April 2020. Epidemiology 2020.
    1. Office for National Statistics Deaths involving COVID-19, England and Wales: deaths occurring in April 2020. Available:
    1. Public Health England Emergency department: weekly bulletins for 2020, 2020. Available:
    1. Gale CP, Weston C, Denaxas S, et al. . Engaging with the clinical data transparency initiative: a view from the National Institute for cardiovascular outcomes research (NICOR). Heart 2012;98:1040–3. 10.1136/heartjnl-2012-302469
    1. Denaxas S. OurRisk.CoV (prototype), 2020. Available: [Accessed 25 Jun 2020].
    1. British Heart Foundation Improving the nation’s cardio-vascular health: the BHF Data Science Centre, 2019. Available:
    1. Shah ASV, Anand A, Strachan FE, et al. . High-Sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet 2018;392:919–28. 10.1016/S0140-6736(18)31923-8
    1. Bégaud B, Martin K, Abouelfath A, et al. . An easy to use method to approximate Poisson confidence limits. Eur J Epidemiol 2005;20:213–6. 10.1007/s10654-004-6517-4
    1. Johal AS, Loftus IM, Boyle JR, et al. . Changing patterns of carotid endarterectomy between 2011 and 2017 in England. Stroke 2019;50:2461–8. 10.1161/STROKEAHA.119.025231
    1. Vascular Society COVID-19 virus and vascular surgery, 2020. Available: [Accessed 1 Jul 2020].
    1. DATA-CAN - The Health Data Research Hub for Cancer. Available:
    1. Health Data Research UK BREATHE - The Health Data Research Hub for Respiratory Health, 2020. Available: [Accessed 25 Jun 2020].
    1. World Health Organization Essential steps for developing or updating a national pandemic influenza preparedness plan, 2018. Available: [Accessed 25 Jun 2020].
    1. Poon MTC, Brennan PM, Jin K, et al. . Tracking excess deaths (TRACKED) – an interactive online tool to monitor excess deaths associated with the COVID-19 pandemic in the United Kingdom. Wellcome Open Res 2020;5:168 10.12688/wellcomeopenres.16058.1
    1. Roser M, Ritchie H, Ortiz-Ospina E, et al. . Coronavirus pandemic (COVID-19). our world in data, 2020. Available: [Accessed 26 Jun 2020].
    1. Lai RK, Recht LD, Reardon DA, et al. . Long-Term follow-up of act III: a phase II trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma. Neuro-Oncology 2011;13.
    1. Saban M, Reznik A, Shachar T, et al. . Reduction in stroke patients’ referral to the ED in the COVID-19 era: A four-year comparative study. Intensive Care Med 2020.
    1. COVIDSurg Collaborative Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg 2020. 10.1002/bjs.11746. [Epub ahead of print: 12 May 2020].
    1. Clinical Effectiveness Unit National vascular registry, 2019. Available:

Source: PubMed

3
Prenumerera